Kunming Institute

Kunming Institute of Biological Products (KIBP) is a prominent Chinese biopharmaceutical company specializing in the research, development, and manufacturing of human vaccines. As a subsidiary of China National Biotec Group (CNBG) under Sinopharm, the institute plays a critical role in China's national immunization programs. Its product portfolio includes widely used vaccines for Hepatitis A, Polio (Sabin strain IPV), and Enterovirus 71 (Hand, Foot, and Mouth Disease). The company operates large-scale GMP-certified manufacturing facilities and maintains a strong focus on infectious disease prevention through advanced virology research. KIBP is recognized for its contributions to global health, particularly in the development of affordable inactivated polio vaccines.